Canaan X

Atmosfy is a platform that specializes in discovering dining and nightlife options through video content. Founded in 2021 and based in San Francisco, California, Atmosfy allows users to explore a variety of venues, including restaurants, bars, nightclubs, and cafes, both locally and remotely. The platform offers video insights alongside user reviews and recommendations, facilitating informed decision-making for individuals seeking dining and entertainment experiences. By combining visual content with curated feedback, Atmosfy enhances the way users choose their dining and nightlife destinations.

Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Bzaar is an online B2B cross-border marketplace founded in 2020 and headquartered in San Francisco, California. The company specializes in connecting small businesses with a diverse range of products, including home improvements, fashion, cookware, and bakeware, primarily sourced from South and South-East Asia. Bzaar provides retailers access to niche and artisanal products from value-based brands that are often unavailable at traditional big-box retail chains. By facilitating cross-border wholesale transactions, Bzaar enhances buying transparency and predictability for small and medium enterprises, allowing them to effectively meet their inventory needs.

Juno Residential, Inc. is a company focused on the development of residential apartments, incorporating innovative construction methods to provide environmentally friendly housing solutions. Based in San Francisco, California, Juno specializes in prefabricated houses, utilizing techniques that emphasize speed and efficiency. The company is committed to sustainability, employing organic and low-carbon materials, such as mass timber, in its projects. By offering modern and curated living spaces, Juno aims to address the growing demand for sustainable housing alternatives in urban environments. Founded in 2018, Juno Residential, Inc. was previously known as Lighthouse Residential, Inc.

Leanplum Inc. is a mobile marketing platform that specializes in enhancing engagement for brands through a unified, multichannel approach. Founded in 2012 and headquartered in San Francisco, with additional offices in New York, London, Bulgaria, and Amsterdam, Leanplum enables businesses to optimize their mobile applications and marketing efforts. The platform offers a range of services including messaging, automation, app editing, personalization, A/B testing, and analytics, allowing product teams to conduct real-time optimization tests and analyze results effectively. Renowned global brands such as Tinder, Grab, Tesco, and Zynga utilize Leanplum to orchestrate integrated campaigns that foster customer loyalty and drive growth. By transforming data into actionable insights, Leanplum helps companies understand user needs, delivering relevant experiences that enhance brand engagement and establish long-term customer relationships.

The RealReal, Inc. is the largest online marketplace for authenticated resale luxury goods, headquartered in San Francisco, California. Founded in 2011, the company operates a full-service consignment platform that includes various product categories such as women's, men's, and kids' fashion, fine jewelry, watches, art, and home goods. With over 37 million members, The RealReal has sold nearly 40 million items through a rigorous authentication process managed by a team of skilled experts, including gemologists and horologists. The company emphasizes sustainability by promoting the circular economy, giving new life to luxury items from thousands of brands. It offers a range of services to make selling easy for consignors, including virtual appointments, in-home pickups, and direct shipping. The RealReal generates revenue through consignment and first-party sales, leveraging advanced technology to authenticate items and optimize pricing, which allows it to maintain higher take rates compared to competitors.

Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

IDEAYA Biosciences, Inc., established in 2015 and headquartered in South San Francisco, California, specializes in oncology-focused precision medicine. The company discovers and develops targeted therapeutics for patient populations selected through molecular diagnostics. Its lead product candidate, IDE196, is a protein kinase C inhibitor currently in Phase 1/2 clinical trials for genetically-defined cancers with GNAQ or GNA11 gene mutations. IDEAYA's preclinical pipeline includes programs targeting MAT2A, Pol-theta, PARG, and WRN in various solid tumors. The company collaborates with institutions like Cancer Research UK and Pfizer Inc., and has partnerships with industry leaders such as GlaxoSmithKline plc.

Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Leanplum Inc. is a mobile marketing platform that specializes in enhancing engagement for brands through a unified, multichannel approach. Founded in 2012 and headquartered in San Francisco, with additional offices in New York, London, Bulgaria, and Amsterdam, Leanplum enables businesses to optimize their mobile applications and marketing efforts. The platform offers a range of services including messaging, automation, app editing, personalization, A/B testing, and analytics, allowing product teams to conduct real-time optimization tests and analyze results effectively. Renowned global brands such as Tinder, Grab, Tesco, and Zynga utilize Leanplum to orchestrate integrated campaigns that foster customer loyalty and drive growth. By transforming data into actionable insights, Leanplum helps companies understand user needs, delivering relevant experiences that enhance brand engagement and establish long-term customer relationships.

Ascendify Corporation specializes in developing innovative talent management solutions that transform how companies attract, develop, and retain employees. The company's flagship product, the Intelligent People Management platform, utilizes machine learning and predictive analytics to streamline recruiting and talent development processes. This cloud-based platform enables organizations to effectively identify and connect with potential candidates while also assessing their skills and training needs. Headquartered in San Francisco, Ascendify serves a diverse clientele, including prominent corporations such as GE, Cisco, Panasonic, Disney, Deloitte, and Marriott, reinforcing its position as a key player in the talent acquisition software industry.

Beam Solutions is a venture-backed regulatory technology (regtech) software company based in the San Francisco Bay Area. It specializes in developing an anti-money laundering platform that addresses compliance challenges faced by financial institutions. Beam's proprietary transaction monitoring technologies utilize advanced machine learning and innovative data sources to significantly reduce false positives and enhance the detection of suspicious activities. This end-to-end compliance solution not only improves efficiency but also helps banks, credit unions, and fintech companies navigate the complexities of regulatory requirements. By employing a transparent-box approach, Beam elucidates its machine learning processes, ensuring clarity for regulators and bolstering their understanding and approval. The company is supported by a knowledgeable team of officers, directors, advisors, and investors.

Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Cardlytics, Inc. operates an advertising platform that integrates with the digital channels of financial institutions, including online and mobile banking, email, and real-time notifications, primarily in the United States and the United Kingdom. Founded in 2008 and headquartered in Atlanta, Georgia, the company partners with over 1,500 financial institutions, such as Bank of America and PNC, to enhance customer loyalty through banking rewards programs. Utilizing purchase-based intelligence, Cardlytics enables marketers to effectively identify, reach, and influence potential buyers while accurately measuring the impact of their marketing campaigns. The company's primary offering, the Cardlytics Direct solution, serves as a native advertising channel within banking platforms, allowing marketers to connect with consumers in a trusted environment. Additionally, Cardlytics provides other platform solutions that leverage purchase insights outside the banking context, further enhancing marketers' capabilities to engage with their target audience.

Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Leanplum Inc. is a mobile marketing platform that specializes in enhancing engagement for brands through a unified, multichannel approach. Founded in 2012 and headquartered in San Francisco, with additional offices in New York, London, Bulgaria, and Amsterdam, Leanplum enables businesses to optimize their mobile applications and marketing efforts. The platform offers a range of services including messaging, automation, app editing, personalization, A/B testing, and analytics, allowing product teams to conduct real-time optimization tests and analyze results effectively. Renowned global brands such as Tinder, Grab, Tesco, and Zynga utilize Leanplum to orchestrate integrated campaigns that foster customer loyalty and drive growth. By transforming data into actionable insights, Leanplum helps companies understand user needs, delivering relevant experiences that enhance brand engagement and establish long-term customer relationships.

IDEAYA Biosciences, Inc., established in 2015 and headquartered in South San Francisco, California, specializes in oncology-focused precision medicine. The company discovers and develops targeted therapeutics for patient populations selected through molecular diagnostics. Its lead product candidate, IDE196, is a protein kinase C inhibitor currently in Phase 1/2 clinical trials for genetically-defined cancers with GNAQ or GNA11 gene mutations. IDEAYA's preclinical pipeline includes programs targeting MAT2A, Pol-theta, PARG, and WRN in various solid tumors. The company collaborates with institutions like Cancer Research UK and Pfizer Inc., and has partnerships with industry leaders such as GlaxoSmithKline plc.

The RealReal, Inc. is the largest online marketplace for authenticated resale luxury goods, headquartered in San Francisco, California. Founded in 2011, the company operates a full-service consignment platform that includes various product categories such as women's, men's, and kids' fashion, fine jewelry, watches, art, and home goods. With over 37 million members, The RealReal has sold nearly 40 million items through a rigorous authentication process managed by a team of skilled experts, including gemologists and horologists. The company emphasizes sustainability by promoting the circular economy, giving new life to luxury items from thousands of brands. It offers a range of services to make selling easy for consignors, including virtual appointments, in-home pickups, and direct shipping. The RealReal generates revenue through consignment and first-party sales, leveraging advanced technology to authenticate items and optimize pricing, which allows it to maintain higher take rates compared to competitors.

Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

The RealReal, Inc. is the largest online marketplace for authenticated resale luxury goods, headquartered in San Francisco, California. Founded in 2011, the company operates a full-service consignment platform that includes various product categories such as women's, men's, and kids' fashion, fine jewelry, watches, art, and home goods. With over 37 million members, The RealReal has sold nearly 40 million items through a rigorous authentication process managed by a team of skilled experts, including gemologists and horologists. The company emphasizes sustainability by promoting the circular economy, giving new life to luxury items from thousands of brands. It offers a range of services to make selling easy for consignors, including virtual appointments, in-home pickups, and direct shipping. The RealReal generates revenue through consignment and first-party sales, leveraging advanced technology to authenticate items and optimize pricing, which allows it to maintain higher take rates compared to competitors.

CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company based in South San Francisco, California. It specializes in developing a novel class of antibody therapeutics utilizing its Probody technology platform, which aims to enhance the targeting of tumors while minimizing drug activity in healthy tissues. The company's clinical-stage product candidates include CX-072, a therapeutic targeting programmed cell death ligand 1; CX-2009, a drug conjugate targeting CD166; BMS-986249 and BMS-986288, both targeting CTLA-4 for metastatic melanoma and solid tumors; and CX-2029, a drug conjugate for CD71 in solid tumors. CytomX collaborates strategically with several industry leaders, including AbbVie, Amgen, and Bristol-Myers Squibb, to advance its Probody therapeutics. Founded in 2008, CytomX Therapeutics is committed to providing innovative and less toxic treatment options for patients with severe illnesses such as cancer.

The RealReal, Inc. is the largest online marketplace for authenticated resale luxury goods, headquartered in San Francisco, California. Founded in 2011, the company operates a full-service consignment platform that includes various product categories such as women's, men's, and kids' fashion, fine jewelry, watches, art, and home goods. With over 37 million members, The RealReal has sold nearly 40 million items through a rigorous authentication process managed by a team of skilled experts, including gemologists and horologists. The company emphasizes sustainability by promoting the circular economy, giving new life to luxury items from thousands of brands. It offers a range of services to make selling easy for consignors, including virtual appointments, in-home pickups, and direct shipping. The RealReal generates revenue through consignment and first-party sales, leveraging advanced technology to authenticate items and optimize pricing, which allows it to maintain higher take rates compared to competitors.

Cuyana, Inc. is a San Francisco-based fashion brand that focuses on manufacturing and retailing high-quality clothing, bodysuits, bags, small leather goods, and accessories. Founded in 2011, the company promotes the philosophy of "fewer, better things," offering timeless pieces designed with a modern aesthetic and crafted from premium materials to ensure durability. Cuyana operates an online platform for direct-to-consumer sales, allowing it to provide luxury-quality products at attainable prices. In addition to its online presence, Cuyana has physical showrooms in locations such as Palo Alto, New York City, Pacific Palisades, and Venice. Through its unique approach, Cuyana aims to bridge the gap between luxury and affordability in the fashion industry.

The RealReal, Inc. is the largest online marketplace for authenticated resale luxury goods, headquartered in San Francisco, California. Founded in 2011, the company operates a full-service consignment platform that includes various product categories such as women's, men's, and kids' fashion, fine jewelry, watches, art, and home goods. With over 37 million members, The RealReal has sold nearly 40 million items through a rigorous authentication process managed by a team of skilled experts, including gemologists and horologists. The company emphasizes sustainability by promoting the circular economy, giving new life to luxury items from thousands of brands. It offers a range of services to make selling easy for consignors, including virtual appointments, in-home pickups, and direct shipping. The RealReal generates revenue through consignment and first-party sales, leveraging advanced technology to authenticate items and optimize pricing, which allows it to maintain higher take rates compared to competitors.

Near Pte. Ltd., also known as AdNear, operates a location-based intelligence platform that delivers real-time insights about places, people, and products. Founded in 2012 and headquartered in Singapore, the company specializes in data-driven solutions that help brands and publishers engage and analyze audiences. Its offerings include Allspark, a mobile-first audience cloud solution, and Carbon, which analyzes real-world consumer behavior across significant locations. Near's platform processes data from approximately 1.6 billion unique user IDs and 70 million points of interest across over 44 countries, enabling clients to better understand consumer behaviors and preferences. The company serves a diverse range of industries, including retail, technology, travel, telecommunications, and financial services, with additional offices in major global cities such as San Francisco, New York, London, Bengaluru, Tokyo, and Sydney.

CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company based in South San Francisco, California. It specializes in developing a novel class of antibody therapeutics utilizing its Probody technology platform, which aims to enhance the targeting of tumors while minimizing drug activity in healthy tissues. The company's clinical-stage product candidates include CX-072, a therapeutic targeting programmed cell death ligand 1; CX-2009, a drug conjugate targeting CD166; BMS-986249 and BMS-986288, both targeting CTLA-4 for metastatic melanoma and solid tumors; and CX-2029, a drug conjugate for CD71 in solid tumors. CytomX collaborates strategically with several industry leaders, including AbbVie, Amgen, and Bristol-Myers Squibb, to advance its Probody therapeutics. Founded in 2008, CytomX Therapeutics is committed to providing innovative and less toxic treatment options for patients with severe illnesses such as cancer.

The RealReal, Inc. is the largest online marketplace for authenticated resale luxury goods, headquartered in San Francisco, California. Founded in 2011, the company operates a full-service consignment platform that includes various product categories such as women's, men's, and kids' fashion, fine jewelry, watches, art, and home goods. With over 37 million members, The RealReal has sold nearly 40 million items through a rigorous authentication process managed by a team of skilled experts, including gemologists and horologists. The company emphasizes sustainability by promoting the circular economy, giving new life to luxury items from thousands of brands. It offers a range of services to make selling easy for consignors, including virtual appointments, in-home pickups, and direct shipping. The RealReal generates revenue through consignment and first-party sales, leveraging advanced technology to authenticate items and optimize pricing, which allows it to maintain higher take rates compared to competitors.

Cardlytics, Inc. operates an advertising platform that integrates with the digital channels of financial institutions, including online and mobile banking, email, and real-time notifications, primarily in the United States and the United Kingdom. Founded in 2008 and headquartered in Atlanta, Georgia, the company partners with over 1,500 financial institutions, such as Bank of America and PNC, to enhance customer loyalty through banking rewards programs. Utilizing purchase-based intelligence, Cardlytics enables marketers to effectively identify, reach, and influence potential buyers while accurately measuring the impact of their marketing campaigns. The company's primary offering, the Cardlytics Direct solution, serves as a native advertising channel within banking platforms, allowing marketers to connect with consumers in a trusted environment. Additionally, Cardlytics provides other platform solutions that leverage purchase insights outside the banking context, further enhancing marketers' capabilities to engage with their target audience.

Blurb, Inc. operates a self-publishing and marketing platform that allows users to create and publish a variety of books and magazines in both print and digital formats. Founded in 2005 and headquartered in San Francisco with an additional office in London, the company offers tools such as an Adobe InDesign plug-in and BookWright, enabling users to design and layout books, photo books, and magazines. Blurb caters to a diverse range of publishing needs, including trade books, photography, memoirs, and personalized keepsakes. Authors can utilize Blurb's platform to sell their works directly through their own websites or social media, with the company managing the printing and shipping of orders. Blurb is recognized for its focus on high-quality coffee table books and fixed-format ebooks, making it a popular choice for both professional and amateur creators. As of August 2020, Blurb operates as a subsidiary of Reischling Press, Inc.

Blurb, Inc. operates a self-publishing and marketing platform that allows users to create and publish a variety of books and magazines in both print and digital formats. Founded in 2005 and headquartered in San Francisco with an additional office in London, the company offers tools such as an Adobe InDesign plug-in and BookWright, enabling users to design and layout books, photo books, and magazines. Blurb caters to a diverse range of publishing needs, including trade books, photography, memoirs, and personalized keepsakes. Authors can utilize Blurb's platform to sell their works directly through their own websites or social media, with the company managing the printing and shipping of orders. Blurb is recognized for its focus on high-quality coffee table books and fixed-format ebooks, making it a popular choice for both professional and amateur creators. As of August 2020, Blurb operates as a subsidiary of Reischling Press, Inc.

Blurb, Inc. operates a self-publishing and marketing platform that allows users to create and publish a variety of books and magazines in both print and digital formats. Founded in 2005 and headquartered in San Francisco with an additional office in London, the company offers tools such as an Adobe InDesign plug-in and BookWright, enabling users to design and layout books, photo books, and magazines. Blurb caters to a diverse range of publishing needs, including trade books, photography, memoirs, and personalized keepsakes. Authors can utilize Blurb's platform to sell their works directly through their own websites or social media, with the company managing the printing and shipping of orders. Blurb is recognized for its focus on high-quality coffee table books and fixed-format ebooks, making it a popular choice for both professional and amateur creators. As of August 2020, Blurb operates as a subsidiary of Reischling Press, Inc.

Loyalty Lab, Inc. is a company that specializes in customer relationship management (CRM) solutions, offering a comprehensive CRM suite designed as a software-as-a-service. Founded in 2003 and headquartered in San Francisco, California, Loyalty Lab provides a web-based platform that enables online travel retailers and service companies to manage loyalty programs effectively. The company's integrated offerings include email messaging, promotions and incentives management, and campaign management solutions, all aimed at enhancing marketing efforts and customer engagement. Previously known as InStorecard, Inc., Loyalty Lab continues to focus on delivering innovative CRM solutions to its clients.

Loyalty Lab, Inc. is a company that specializes in customer relationship management (CRM) solutions, offering a comprehensive CRM suite designed as a software-as-a-service. Founded in 2003 and headquartered in San Francisco, California, Loyalty Lab provides a web-based platform that enables online travel retailers and service companies to manage loyalty programs effectively. The company's integrated offerings include email messaging, promotions and incentives management, and campaign management solutions, all aimed at enhancing marketing efforts and customer engagement. Previously known as InStorecard, Inc., Loyalty Lab continues to focus on delivering innovative CRM solutions to its clients.

Located in San Francisco's SOMA district, User Interface, Inc. offers B2B companies the technology and the strategies necessary to forge stronger company-customer relationships. User Interface clients, including Cisco Systems, Digital Island, Commerce One and Informatica, rely on the company for assistance with gathering and leveraging contextual intelligence on customers. To increase customer satisfaction and retention, companies need to understand their customers. Working with major B2B technology companies, User Interface has developed detailed methodologies for gathering, analyzing, and distributing customer intelligence. Underlying those methodologies is the Customer Intelligence System (CIS), which offers their clients easy access to post-sales customer information.